canertinib dihydrochloride has been researched along with mln8054 in 1 studies
| Studies (canertinib dihydrochloride) | Trials (canertinib dihydrochloride) | Recent Studies (post-2010) (canertinib dihydrochloride) | Studies (mln8054) | Trials (mln8054) | Recent Studies (post-2010) (mln8054) |
|---|---|---|---|---|---|
| 31 | 13 | 6 | 61 | 3 | 42 |
| Protein | Taxonomy | canertinib dihydrochloride (IC50) | mln8054 (IC50) |
|---|---|---|---|
| Aurora kinase A | Homo sapiens (human) | 0.0398 | |
| Aurora kinase B | Mus musculus (house mouse) | 0.172 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.2 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | 0.33 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.7943 | |
| Aurora kinase A | Mus musculus (house mouse) | 0.0085 | |
| Aurora kinase B | Homo sapiens (human) | 1.6916 | |
| Aurora kinase C | Homo sapiens (human) | 0.0118 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russu, WA; Shallal, HM | 1 |
1 other study(ies) available for canertinib dihydrochloride and mln8054
| Article | Year |
|---|---|
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |